PAX-1 is under clinical development by Komipharm International and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase I drugs for Metastatic Ovarian Cancer have a 77% ...
1Lab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium. 2Lab of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrijie ...
Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. In recent years, there has been significant progress in the ...